Related Experiment Video
Updated: Apr 20, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Safety of Outpatient Implantation of the Implantable Cardioverter-defibrillator
Tomás Datino1, Ángel Miracle Blanco1, Alberto Núñez García1
1Departamento de Medicina, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria del Hospital General Universitario Gregorio Marañón, Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Insights
Outpatient implantation of cardioverter-defibrillators is safe and cost-effective. This approach reduces healthcare expenses while maintaining similar complication rates compared to inpatient procedures.
Area of Science:
- Cardiology
- Health Economics
Background:
- Healthcare systems face pressure to reduce costs and enhance patient care.
- Implantable cardioverter-defibrillators (ICDs) are crucial for managing cardiac arrhythmias.
- The setting for ICD implantation (outpatient vs. inpatient) impacts resource utilization and patient outcomes.
Purpose of the Study:
- To evaluate the safety and cost-effectiveness of outpatient implantation of implantable cardioverter-defibrillators.
- To compare complication rates between outpatient and inpatient ICD implantation procedures.
Main Methods:
- A retrospective analysis of 401 patients who underwent ICD implantation between 2007 and 2012.
- Comparison of intervention-related complication rates in 232 outpatients versus 169 inpatients.
- Multivariate analysis to identify factors associated with post-implantation complications.
Main Results:
- Outpatient ICD implantation was associated with significant cost savings of approximately €735 per procedure.
- Complication rates were similar between outpatient (6.0%) and inpatient (5.3%) settings within three months post-implantation.
- Previous anticoagulant therapy was identified as a predictor of complications, primarily pocket hematomas.
Conclusions:
- Outpatient implantation of implantable cardioverter-defibrillators is a safe and economically beneficial strategy.
- Patients on chronic anticoagulation therapy require close monitoring due to an elevated risk of complications.
- This approach offers a viable method for reducing healthcare expenditure without compromising patient safety.
Introduction And Objectives:
Strategies are needed to reduce health care costs and improve patient care. The objective of our study was to analyze the safety of outpatient implantation of cardioverter-defibrillators.
Methods:
A retrospective study was conducted in 401 consecutive patients who received an implantable cardioverter-defibrillator between 2007 and 2012. The rate of intervention-related complications was compared between 232 patients (58%) whose implantation was performed in the outpatient setting and 169 patients (42%) whose intervention was performed in the inpatient setting.
Results:
The mean age (standard deviation) of the patients was 62 (14) years; 336 (84%) were male. Outpatients had lower left ventricular ejection fraction and a higher percentage had an indication for primary prevention of sudden death, compared to inpatients. Only 21 outpatients (9%) required subsequent hospitalization. The rate of complications until the third month postimplantation was similar for outpatients (6.0%) and inpatients (5.3%); P = .763. In multivariate analysis, only previous anticoagulant therapy was related to the presence of complications (odds ratio = 3.2; 95% confidence interval, 1.4-7.4; P < .01), mainly due to an increased rate of pocket hematomas. Each outpatient implantation saved approximately €735.
Conclusions:
Outpatient implantation of implantable cardioverter-defibrillators is safe and reduces costs. Close observation is recommended for patients receiving chronic anticoagulation therapy due to an increased risk of complications.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Holter Monitor: 24-Hour Monitoring

